Short answer
OPKO HEALTH, INC. (OPK) filed an 8-K current report with the SEC on August 14, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement). OPKO issued $125 million of additional senior secured notes, increasing debt backed by future royalty cash flows.
OPKO HEALTH, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- OPKO issued $125 million of additional senior secured notes, increasing debt backed by future royalty cash flows
- Notes mature July 17, 2044, with interest at three-month SOFR plus 7.5%, subject to a 4.0% floor
- Quarterly interest depends on Pfizer profit-share payments, creating repayment sensitivity to royalty performance
- EirGen’s mazdutide royalty payments provide secondary interest support and principal repayment, capped at $187.5 million
- Covenants restrict additional debt, liens, asset sales, and material contract amendments; cross-default provisions heighten financing risk
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other OPKO HEALTH, INC. 8-K filings
Get the next OPK 8-K as it lands
Follow OPK for push alerts, or ask the research agent what this filing means.